Skip to main content
SpringerLink
Log in

Dying cells program their expedient disposal: serum amyloid P component upregulation in vivo and in vitro induced by photodynamic therapy of cancer

  • Paper
  • Published:
Photochemical & Photobiological Sciences Aims and scope Submit manuscript

Abstract

Serum amyloid P component (SAP) is known as a prototypic acute phase reactant in the mouse and the protein that binds to dying cells securing their swift disposal by phagocytes. Treatment of solid tumors by photodynamic therapy (PDT) triggers SAP production in the liver of host mice, its release in the circulation and accumulation in PDT-targeted lesions. In the present study, mouse Lewis lung carcinoma (LLC) cells treated in vitro by PDT are shown to upregulate their gene encoding SAP. This effect was manifested following PDT treatment mediated by various types of photosensitizers (Photofrin, BPD, mTHPC, ALA). Generated SAP protein was not detected in tissue supernatants but remained localized to producing PDT-treated cells. The upregulation of SAP gene was observed also in untreated IC-21 macrophages after they were co-incubated for 4 h with PDT-treated LLC cells. Based on these findings, SAP that accumulates in PDT-treated tumors may originate from both systemic sources (released from the liver as acute phase reactant) and local sources; the latter could include tumor cells directly sustaining PDT injury and macrophages invading the tumor that become stimulated by signals from these affected tumor cells. Since SAP gene upregulation in LLC cells increased with the lethality of PDT dose used for their treatment, we propose that cells sensing they are inflicted with mortal injury can turn on molecular programs insuring not only that they die an innocuous form of death (apoptosis) but also that once they are dead their elimination is (facilitated by SAP) swift and efficient.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. T. J. Dougherty, C. J. Gomer, B. W. Henderson, G. Jori, D. Kessel, M. Korbelik, J. Moan, Q. Peng, Photodynamic therapy, J. Natl. Cancer Inst., 1998, 90, 899–905.

    Article  Google Scholar 

  2. Z. Huang, A review of progress in clinical photodynamic therapy, Technol. Cancer Res. Treat., 2005, 4, 283–294.

    Article  CAS  Google Scholar 

  3. B. W. Henderson, T. J. Dougherty, How does photodynamic therapy work?, Photochem. Photobiol., 1992, 55, 145–57.

    Article  CAS  Google Scholar 

  4. M. Korbelik and I. Cecic, Mechanism of tumor destruction by photodynamic therapy, in Handbook of Photochemistry and Photobiology, ed. H. S. Nalwa, American Scientific Publishers, Stevenson Ranch, CA, 2003, vol. 4, pp. 39–77.

    CAS  Google Scholar 

  5. M. Korbelik, PDT-associated host response and its role in the therapy outcome, Lasers Surg. Med., 2006, 38, 500–508.

    Article  Google Scholar 

  6. A. M. deCathelineau, P. M. Henson, The final step in programmed cell death: phagocytes carry apoptotic cells to the grave, Essays Biochem., 2003, 39, 105–117.

    Article  CAS  Google Scholar 

  7. G. Majai, G. Petrovski, L. Fesus, Inflammation and the apopto-phagocytic system, Immunol. Lett., 2006, 104, 94–101.

    Article  CAS  Google Scholar 

  8. A. A. Manfredi, M. Iannacone, F. D’Auria, P. Rovere-Querini, The disposal of dying cells in living tissue, Apoptosis, 2002, 7, 153–161.

    Article  CAS  Google Scholar 

  9. M. Korbelik, S. Merchant, B. Stott, I. Cecic, P. Payne, J. Sun, Acute phase response induced following tumor treatment by photodynamic therapy: relevance for the therapy outcome, Proc. SPIE-Int. Soc. Opt. Eng., 2006, 6087, C1–C7.

    Google Scholar 

  10. M. Korbelik, I. Cecic, S. Merchant and J. Sun, Acute phase response induction by cancer treatment with photodynamic therapy, Int. J. Cancer, accepted.

  11. P. T. Le, M. T. Muller, R. F. Mortensen, Acute phase reactants of mice. I. Isolation, of serum amyloid P-component (SAP) and its induction by a monokine, J. Immunol., 1982, 129, 665–672.

    CAS  PubMed  Google Scholar 

  12. C. Garlanda, B. Botazzi, A. Bastone, A. Mantovani, Pentraxins at the crossroads between innate immunity, inflammation, matrix deposition, and female fertility, Annu. Rev. Immunol., 2005, 23, 337–366.

    Article  CAS  Google Scholar 

  13. Y. S. Taktak, B. Stenning, Solid phase enzyme immunoassays for the quantification of serum amyloid P (SAP) and complement component 3 (C3) proteins in acute-phase mouse sera, Horm. Metab. Res., 1992, 24, 371–374.

    Article  CAS  Google Scholar 

  14. M. Korbelik, J. Sun, I. Cecic, Photodynamic therapy-induced cell surface expression and release of heat shock proteins: relevance for tumor response, Cancer Res., 65, 1018‐1026.

  15. B. Stott, M. Korbelik, Activation of complement C3, C5, and C9 genes in tumors treated by photodynamic therapy, Cancer Immunol. Immunother., 2007, 56, 649–659.

    Article  CAS  Google Scholar 

  16. I. Cecic, J. Sun, M. Korbelik, Role of complement anaphylatoxin C3a in photodynamic therapy-elicited engagement of host neutrophils and other immune cells, Photochem. Photobiol., 2006, 82, 558–562.

    Article  CAS  Google Scholar 

  17. I. Cecic, I. B. Stott, M. Korbelik, Acute phase response-associated systemic neutrophil mobilization in mice bearing tumors treated by photodynamic therapy, Int. Immunopharmacol., 2006, 6, 1259–1266.

    Article  CAS  Google Scholar 

  18. M. C. M. Bickerstaff, M. Botto, W. L. Hutchinson, J. Herbert, G. A. Tennet, A. Bybee, D. A. Mitchell, H. T. Cook, P. J. G. Butler, M. J. Walport, M. B. Pepys, Serum amyloid P component controls chromatin degradation and prevents antinuclear autoimmunity, Nat. Med., 1999, 5, 694–697.

    Article  CAS  Google Scholar 

  19. M. Bijl, G. Horst, J. Bijzet, H. Bootsma, P. C. Limburg, C. G. M. Kallenberg, Serum amyloid P component binds to late apoptotic cells and mediates their uptake by monocytes-derived macrophages, Arthritis Rheum., 2003, 48, 248–254.

    Article  CAS  Google Scholar 

  20. N. L. Oleinick, R. L. Morris, Irina Belichenko, The role of apoptosis in response to photodynamic therapy: what, why, and how, Photochem. Photobiol. Sci., 2002, 1, 1–21.

    Article  CAS  Google Scholar 

  21. S. M. Breathnach, H. Kofler, N. Sepp, J. Ashworth, D. Woodrow, M. B. Pepys, H. Hintner, Serum amyloid P component binds to cell nuclei in vitro and to in vivo deposits of extracellular chromatin in systemic lupus erythematosus, J. Exp. Med., 1989, 170, 1433–1438.

    Article  CAS  Google Scholar 

  22. A. Familian, B. Zwart, H. G. Huisman, I. Rensink, D. Roem, P. L. Hordijk, L. A. Aarden, C. E. Hack, Chromatin-independent binding of serum amyloid P component to apoptotic cells, J. Immunol., 2001, 167, 647–654.

    Article  CAS  Google Scholar 

  23. C. Mold, H. D. Gresham, T. W. Du Clos, Serum amyloid P component and C-reactive protein mediate phagocytosis through murine Fc gamma Rs, J. Immunol., 2001, 166, 1200–1205.

    Article  CAS  Google Scholar 

  24. K. B. Bodman-Smith, A. J. Melendez, I. Campbell, P. T. Harrison, J. M. Allen, J. G. Raynes, C-reactive protein-mediated phagocytosis and Phospholipase D signaling through the high-affinity receptor for immunoglobulin G (Fc?R1), Immunology, 2002, 107, 252–260.

    Article  CAS  Google Scholar 

  25. M. S. Kravitz, M. Pitashny, Y. Shoenfld, Protective molecules-C-reactive protein (CRP), serum amyloid P (SAP), pentraxin 3 (PTX3), mannose-binding lectin (MBL), and apolipoprotein A1 (Apo A1), and their autoantibodies: prevalence and clinical significance in autoimmunity, J. Clin. Immunol., 2005, 25, 582–591.

    Article  CAS  Google Scholar 

  26. L. Marnell, C. Mold, T. W. Du Clos, C-reactive protein: ligands, receptors and role in inflammation, Clin. Immunol., 2005, 117, 104–111.

    Article  CAS  Google Scholar 

  27. W. L. Hutchinson, G. E. Noble, P. N. Hawkins, M. B. Pepys, The pentraxins, C-reactive protein and serum amyloid P component, are cleared and catabolized by hepatocytes in vivo, J. Clin. Invest., 1994, 94, 1390–1396.

    Article  CAS  Google Scholar 

  28. T. Fink, Oxygen radicals and signaling, Curr. Opin. Cell Biol., 1998, 10, 248–253.

    Article  Google Scholar 

  29. T. Fink, Oxidant signals and oxidative stress, Curr. Opin. Cell Biol., 2003, 15, 247–2534.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. British Columbia Cancer Agency, 675 West 10th Avenue, Vancouver, B.C., Canada

    Soroush Merchant, Jinghai Sun & Mladen Korbelik

Authors
  1. Soroush Merchant
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jinghai Sun
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Mladen Korbelik
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Mladen Korbelik.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Merchant, S., Sun, J. & Korbelik, M. Dying cells program their expedient disposal: serum amyloid P component upregulation in vivo and in vitro induced by photodynamic therapy of cancer. Photochem Photobiol Sci 6, 1284–1289 (2007). https://doi.org/10.1039/b709439f

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1039/b709439f

Search

Navigation